{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T07:46:55Z","timestamp":1773215215610,"version":"3.50.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T00:00:00Z","timestamp":1756857600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T00:00:00Z","timestamp":1756857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100001006","name":"Breast Cancer Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001006","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Breast cancer mortality rates have declined steadily over the past 40 years, as enhanced screening has shifted the balance of new diagnoses to curable, early-stage cancers while advances in systemic therapy have yielded improved and increasingly durable outcomes even for locally advanced and metastatic disease. However, this reduction in mortality has not been equitably distributed among all racial groups, and there continue to be significant racial and ethnic disparities. In this review, we summarize research that has contributed to our understanding of disparities in breast surgical oncology across all racial\/ethnic groups, however, given that the most egregious disparities exist among Black women, our review will involve considerable focus on this racial group. We will discuss racial disparities across the breast cancer continuum including access to care, diagnosis, surgical treatment, and survivorship and will conclude with strategies to redress them.<\/jats:p>","DOI":"10.1245\/s10434-025-18157-0","type":"journal-article","created":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T16:46:00Z","timestamp":1756917960000},"page":"8621-8627","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Annals of Surgical Oncology Landmark Series Disparities in Surgical Oncology: Breast Cancer"],"prefix":"10.1245","volume":"32","author":[{"given":"Elizabeth M.","family":"De Jesus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leisha C.","family":"Elmore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0876-975X","authenticated-orcid":false,"given":"Oluwadamilola M.","family":"Fayanju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,3]]},"reference":[{"key":"18157_CR1","unstructured":"Society AC Breast Cancer Facts & Figures 2024\u20132025. American Cancer Society, Inc, Atlanta, GA, 2024."},{"key":"18157_CR2","doi-asserted-by":"crossref","first-page":"8056","DOI":"10.1245\/s10434-021-10275-9","volume":"28","author":"W Nizam","year":"2021","unstructured":"Nizam W, et al. Disparities in surgical oncology: management of advanced cancer. Ann Surg Oncol. 2021;28:8056\u201373.","journal-title":"Ann Surg Oncol."},{"key":"18157_CR3","unstructured":"Prevention CFDCA., Breast Cancer Statistics 2024. Centers for Disease Control and Prevention (CDC), agency of the U.S. Department of Health and Human Services, headquartered in Atlanta, GA, 2024."},{"key":"18157_CR4","first-page":"425","volume":"68","author":"KD Mille","year":"2018","unstructured":"Mille KD, et al. Cancer statistics for Hispanics\/Latinos, 2018. CA Cancer J Clin. 2018;68:425\u201345.","journal-title":"CA Cancer J Clin."},{"key":"18157_CR5","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1377\/hlthaff.27.2.374","volume":"27","author":"PL Hebert","year":"2008","unstructured":"Hebert PL, Sisk JE, Howell EA. When does a difference become a disparity? Conceptualizing racial and ethnic disparities in health. Health Aff Millwood. 2008;27:374\u201382.","journal-title":"Health Aff Millwood."},{"key":"18157_CR6","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(17)30569-X","volume":"389","author":"ZD Bailey","year":"2017","unstructured":"Bailey ZD, et al. Structural racism and health inequities in the USA: evidence and interventions. Lancet. 2017;389:1453\u201363.","journal-title":"Lancet."},{"key":"18157_CR7","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/cncr.33310","volume":"127","author":"OM Fayanju","year":"2021","unstructured":"Fayanju OM, et al. Patient-reported causes of distress predict disparities in time to evaluation and time to treatment after breast cancer diagnosis. Cancer. 2021;127:757\u201368.","journal-title":"Cancer."},{"key":"18157_CR8","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1200\/JCO.2005.03.3472","volume":"24","author":"LA Newman","year":"2006","unstructured":"Newman LA, et al. Meta-analysis of survival in African American and white American patients with breast cancer: ethnicity compared with socioeconomic status. J Clin Oncol. 2006;24:1342\u20139.","journal-title":"J Clin Oncol."},{"key":"18157_CR9","doi-asserted-by":"publisher","unstructured":"Patel TA, Jain B, Dee EC, Gomez SL, Vapiwala N, Chino F, Fayanju OM. Delays in time to surgery among Asian and Pacific Islander women with breast cancer. Ann Surg Oncol. 2023;30(9):5337\u201340. https:\/\/doi.org\/10.1245\/s10434-023-13806-8","DOI":"10.1245\/s10434-023-13806-8"},{"key":"18157_CR10","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1002\/cncr.34015","volume":"128","author":"AYL Yu","year":"2022","unstructured":"Yu AYL, et al. Disease characteristics and mortality among Asian women with breast cancer. Cancer. 2022;128:1024\u201337.","journal-title":"Cancer."},{"key":"18157_CR11","doi-asserted-by":"crossref","first-page":"e827","DOI":"10.1200\/OP.20.00381","volume":"18","author":"CD Champion","year":"2022","unstructured":"Champion CD, et al. Disparities at the intersection of race and ethnicity: examining trends and outcomes in Hispanic women with breast cancer. JCO Oncol Pract. 2022;18:e827\u201338.","journal-title":"JCO Oncol Pract."},{"key":"18157_CR12","unstructured":"American Cancer Society. Breast Cancer Facts & Figures 2024-2025. American Cancer Society, Inc., Atlanta, 2024."},{"key":"18157_CR13","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.soc.2023.05.009","volume":"32","author":"LC Elmore","year":"2023","unstructured":"Elmore LC, Fayanju OM. Addressing inequalities in breast cancer care delivery. Surg Oncol Clin North Am. 2023;32:799\u2013810.","journal-title":"Surg Oncol Clin North Am."},{"key":"18157_CR14","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1245\/s10434-022-12535-8","volume":"30","author":"OM Fayanju","year":"2023","unstructured":"Fayanju OM, et al. The landmark series: addressing disparities in breast cancer screening: new recommendations for black women. Ann Surg Oncol. 2023;30:58\u201367.","journal-title":"Ann Surg Oncol."},{"key":"18157_CR15","unstructured":"Meyers D, Brady J, Grace E, Chaves K, Gray D, Barton B. 2021 National Healthcare Quality and Disparities Report. Agency for Healthcare Research and Quality (US), Rockville (MD), 2021."},{"key":"18157_CR16","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1002\/cncr.33473","volume":"127","author":"SD Tait","year":"2021","unstructured":"Tait SD, et al. Characterizing participants in the North Carolina Breast and Cervical Cancer Control Program: a retrospective review of 90,000 women. Cancer. 2021;127:2515\u201324.","journal-title":"Cancer."},{"key":"18157_CR17","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1001\/jamasurg.2020.1495","volume":"155","author":"JM Le Blanc","year":"2020","unstructured":"Le Blanc JM, et al. Association of medicaid expansion under the affordable care act with breast cancer stage at diagnosis. JAMA Surg. 2020;155:752\u20138.","journal-title":"JAMA Surg."},{"key":"18157_CR18","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1200\/JCO.2017.73.7932","volume":"36","author":"A Jemal","year":"2018","unstructured":"Jemal A, et al. Factors that contributed to black-white disparities in survival among nonelderly women with breast cancer between 2004 and 2013. J Clin Oncol. 2018;36:14\u201324.","journal-title":"J Clin Oncol."},{"key":"18157_CR19","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1093\/jbi\/wbaa093","volume":"2","author":"A Mootz","year":"2020","unstructured":"Mootz A, et al. Health care disparities in breast cancer: the economics of access to screening, diagnosis, and treatment. J Breast Imag. 2020;2:524\u20139.","journal-title":"J Breast Imag."},{"key":"18157_CR20","doi-asserted-by":"crossref","first-page":"E140","DOI":"10.5888\/pcd15.180291","volume":"15","author":"S Vang","year":"2018","unstructured":"Vang S, Margolies LR, Jandorf L. Mobile mammography participation among medically underserved women: a systematic review. Prev Chronic Dis. 2018;15:E140.","journal-title":"Prev Chronic Dis."},{"key":"18157_CR21","first-page":"309","volume":"25","author":"JR Palmer","year":"2014","unstructured":"Palmer JR, Ambrosone CB, Olshan AF. A collaborative study of the etiology of breast cancer subtypes in African American women: the AMBER consortium. Cancer Causes Control. 2014;25:309\u201319.","journal-title":"Cancer Causes Control."},{"key":"18157_CR22","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1001\/jamasurg.2017.0005","volume":"152","author":"LA Newman","year":"2017","unstructured":"Newman LA, Kaljee LM. Health disparities and triple-negative breast cancer in African American women: a review. JAMA Surg. 2017;152:485\u201393.","journal-title":"JAMA Surg."},{"key":"18157_CR23","doi-asserted-by":"publisher","unstructured":"Lund MJ, Trivers KF, Porter PL, Coates RJ, Leyland-Jones B, Brawley OW, Flagg EW, O\u2019Regan RM, Gabram SG, Eley JW. Race and triple negative threats to breast cancer survival: a population-based study in Atlanta GA. Breast Cancer Res Treat. 2009;113(2):357\u201370. https:\/\/doi.org\/10.1007\/s10549-008-9926-3","DOI":"10.1007\/s10549-008-9926-3"},{"key":"18157_CR24","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41523-022-00468-0","volume":"8","author":"P Zagami","year":"2022","unstructured":"Zagami P, Carey LA. Triple-negative breast cancer: pitfalls and progress. NPJ Breast Cancer. 2022;8:95.","journal-title":"NPJ Breast Cancer."},{"key":"18157_CR25","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1023\/A:1025481505537","volume":"81","author":"JJ Griggs","year":"2003","unstructured":"Griggs JJ, et al. Racial disparity in the dose and dose intensity of breast cancer adjuvant chemotherapy. Breast Cancer Res Treat. 2003;81:21\u201331.","journal-title":"Breast Cancer Res Treat."},{"key":"18157_CR26","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1056\/NEJMoa2409932","volume":"391","author":"P Schmid","year":"2024","unstructured":"Schmid P, et al. Overall survival with pembrolizumab in early-stage triple-negative breast cancer. N Engl J Med. 2024;391:1981\u201391.","journal-title":"N Engl J Med."},{"key":"18157_CR27","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s10549-017-4166-z","volume":"163","author":"GH Rauscher","year":"2017","unstructured":"Rauscher GH, et al. Racial disparity in survival from estrogen and progesterone receptor-positive breast cancer: implications for reducing breast cancer mortality disparities. Breast Cancer Res Treat. 2017;163:321\u201330.","journal-title":"Breast Cancer Res Treat."},{"key":"18157_CR28","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1200\/JCO.2014.57.1349","volume":"33","author":"ET Warner","year":"2015","unstructured":"Warner ET, et al. Racial and ethnic differences in breast cancer survival: mediating effect of tumor characteristics and sociodemographic and treatment factors. J Clin Oncol. 2015;33:2254\u201361.","journal-title":"J Clin Oncol."},{"key":"18157_CR29","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1002\/cncr.34243","volume":"128","author":"VC Jones","year":"2022","unstructured":"Jones VC, et al. Understanding drivers of the black:white breast cancer mortality gap: a call for more robust definitions. Cancer. 2022;128:2695\u20137.","journal-title":"Cancer."},{"key":"18157_CR30","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1001\/jamaoncol.2015.4508","volume":"2","author":"RJ Bleicher","year":"2016","unstructured":"Bleicher RJ, et al. Time to surgery and breast cancer survival in the United States. JAMA Oncol. 2016;2:330\u20139.","journal-title":"JAMA Oncol."},{"key":"18157_CR31","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1001\/jamaoncol.2015.3856","volume":"2","author":"M Chavez-MacGregor","year":"2016","unstructured":"Chavez-MacGregor M, et al. Delayed initiation of adjuvant chemotherapy among patients with breast cancer. JAMA Oncol. 2016;2:322\u20139.","journal-title":"JAMA Oncol."},{"key":"18157_CR32","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1200\/JCO.2009.27.2427","volume":"28","author":"SA Fedewa","year":"2010","unstructured":"Fedewa SA, et al. Delays in adjuvant chemotherapy treatment among patients with breast cancer are more likely in African American and Hispanic populations: a national cohort study 2004\u20132006. J Clin Oncol. 2010;28:4135\u201341.","journal-title":"J Clin Oncol."},{"key":"18157_CR33","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s10549-018-4909-5","volume":"172","author":"AK Green","year":"2018","unstructured":"Green AK, et al. Racial disparities in chemotherapy administration for early-stage breast cancer: a systematic review and meta-analysis. Breast Cancer Res Treat. 2018;172:247\u201363.","journal-title":"Breast Cancer Res Treat."},{"key":"18157_CR34","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1001\/jamasurg.2014.548","volume":"149","author":"M Morrow","year":"2014","unstructured":"Morrow M, et al. Access to breast reconstruction after mastectomy and patient perspectives on reconstruction decision making. JAMA Surg. 2014;149:1015\u201321.","journal-title":"JAMA Surg."},{"key":"18157_CR35","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.canep.2015.07.010","volume":"39","author":"TF Akinyemiju","year":"2015","unstructured":"Akinyemiju TF, et al. Race\/ethnicity and socio-economic differences in breast cancer surgery outcomes. Cancer Epidemiol. 2015;39:745\u201351.","journal-title":"Cancer Epidemiol."},{"key":"18157_CR36","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1097\/XCS.0000000000000143","volume":"234","author":"MM Sarver","year":"2022","unstructured":"Sarver MM, et al. Racial and ethnic disparities in surgical outcomes after postmastectomy breast reconstruction. J Am Coll Surg. 2022;234:760\u201371.","journal-title":"J Am Coll Surg."},{"key":"18157_CR37","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.ejso.2019.01.016","volume":"45","author":"EJ Mets","year":"2019","unstructured":"Mets EJ, et al. Persistent disparities in breast cancer surgical outcomes among hispanic and African American patients. Eur J Surg Oncol. 2019;45:584\u201390.","journal-title":"Eur J Surg Oncol."},{"key":"18157_CR38","doi-asserted-by":"crossref","first-page":"6099","DOI":"10.1245\/s10434-021-10487-z","volume":"28","author":"PD Butler","year":"2021","unstructured":"Butler PD, Morris MP, Momoh AO. Persistent disparities in postmastectomy breast reconstruction and strategies for mitigation. Ann Surg Oncol. 2021;28:6099\u2013108.","journal-title":"Ann Surg Oncol."},{"key":"18157_CR39","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.amjsurg.2014.11.002","volume":"209","author":"PD Butler","year":"2015","unstructured":"Butler PD, et al. African-American women have equivalent outcomes following autologous free-flap breast reconstruction despite greater preoperative risk factors. Am J Surg. 2015;209:589\u201396.","journal-title":"Am J Surg."},{"key":"18157_CR40","doi-asserted-by":"crossref","first-page":"e031763","DOI":"10.1136\/bmjopen-2019-031763","volume":"9","author":"H Bomhof-Roordink","year":"2019","unstructured":"Bomhof-Roordink H, et al. Key components of shared decision making models: a systematic review. BMJ Open. 2019;9:e031763.","journal-title":"BMJ Open."},{"key":"18157_CR41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-319-16366-6_1","volume":"862","author":"PA Ganz","year":"2015","unstructured":"Ganz PA, Goodwin PJ. Breast cancer survivorship: where are we today? Adv Exp Med Biol. 2015;862:1\u20138.","journal-title":"Adv Exp Med Biol."},{"key":"18157_CR42","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/s11764-021-01046-2","volume":"16","author":"P Advani","year":"2022","unstructured":"Advani P, et al. Racial\/ethnic disparities in use of surveillance mammogram among breast cancer survivors: a systematic review. J Cancer Surviv. 2022;16:514\u201330.","journal-title":"J Cancer Surviv."},{"key":"18157_CR43","first-page":"808","volume":"32","author":"Y Liu","year":"2024","unstructured":"Liu Y, et al. Perceptions, facilitators, and barriers of participation for a behavioral weight loss group-based telehealth program for breast cancer survivors: a qualitative study. Support Care Cancer. 2024;32:808.","journal-title":"Support Care Cancer."},{"key":"18157_CR44","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1001\/jama.295.13.1549","volume":"295","author":"CL Ogden","year":"2006","unstructured":"Ogden CL, et al. Prevalence of overweight and obesity in the United States, 1999\u20132004. JAMA. 2006;295:549\u201355.","journal-title":"JAMA."},{"key":"18157_CR45","doi-asserted-by":"crossref","first-page":"4024","DOI":"10.1002\/cncr.27389","volume":"118","author":"RJ Paxton","year":"2012","unstructured":"Paxton RJ, et al. Associations among physical activity, body mass index, and health-related quality of life by race\/ethnicity in a diverse sample of breast cancer survivors. Cancer. 2012;118:4024\u201331.","journal-title":"Cancer."},{"key":"18157_CR46","first-page":"1387","volume":"21","author":"M Schootman","year":"2010","unstructured":"Schootman M, et al. National estimates of racial disparities in health status and behavioral risk factors among long-term cancer survivors and non-cancer controls. Cancer Causes Control. 2010;21:1387\u201395.","journal-title":"Cancer Causes Control."},{"key":"18157_CR47","doi-asserted-by":"crossref","unstructured":"Meier DE, Brawley OW. Palliative care and the quality of life. J Clin Oncol. 2011;29(20):2750\u201352.","DOI":"10.1200\/JCO.2011.35.9729"},{"issue":"Suppl","key":"18157_CR48","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.4103\/0973-1075.76233","volume":"17","author":"PS Devi","year":"2011","unstructured":"Devi PS. A timely referral to palliative care team improves quality of life. Indian J Palliat Care. 2011;17(Suppl):S14\u20136.","journal-title":"Indian J Palliat Care."},{"key":"18157_CR49","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/01.PCAMA.0000300408.00325.1c","volume":"12","author":"SK Eues","year":"2007","unstructured":"Eues SK. End-of-life care: improving quality of life at the end of life. Prof Case Manag. 2007;12:339\u201344.","journal-title":"Prof Case Manag."},{"key":"18157_CR50","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.21037\/apm-22-770","volume":"11","author":"KE Kopecky","year":"2022","unstructured":"Kopecky KE, et al. Palliative care interventions for surgical patients: a narrative review. Ann Palliat Med. 2022;11:3530\u201341.","journal-title":"Ann Palliat Med."},{"key":"18157_CR51","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1089\/jpm.2023.0547","volume":"27","author":"JQ Freeman","year":"2024","unstructured":"Freeman JQ, et al. Palliative care use trends, racial\/ethnic disparities, and overall survival differences among patients with metastatic breast cancer. J Palliat Med. 2024;27:763\u201375.","journal-title":"J Palliat Med."},{"key":"18157_CR52","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1177\/1049909120922779","volume":"38","author":"K Lee","year":"2021","unstructured":"Lee K, et al. Racial disparities in utilization of palliative care among patients admitted with advanced solid organ malignancies. Am J Hosp Palliat Care. 2021;38:539\u201346.","journal-title":"Am J Hosp Palliat Care."},{"key":"18157_CR53","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1089\/jpm.2013.9468","volume":"16","author":"KS Johnson","year":"2013","unstructured":"Johnson KS. Racial and ethnic disparities in palliative care. J Palliat Med. 2013;16:1329\u201334.","journal-title":"J Palliat Med."},{"key":"18157_CR54","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1089\/jpm.2018.0366","volume":"22","author":"FM Johnston","year":"2019","unstructured":"Johnston FM, et al. Stakeholder perspectives on the use of community health workers to improve palliative care use by African Americans with cancer. J Palliat Med. 2019;22:302\u20136.","journal-title":"J Palliat Med."},{"key":"18157_CR55","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0277-9536(99)00338-X","volume":"50","author":"M van Ryn","year":"2000","unstructured":"van Ryn M, Burke J. The effect of patient race and socio-economic status on physicians\u2019 perceptions of patients. Soc Sci Med. 2000;50:813\u201328.","journal-title":"Soc Sci Med."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18157-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-18157-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18157-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T15:40:30Z","timestamp":1760715630000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-18157-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,3]]},"references-count":55,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["18157"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-18157-0","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,3]]},"assertion":[{"value":"21 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Fayanju is supported by the Breast Cancer Research Foundation and philanthropic funds from the Haas family. She also reports research support unrelated to this work from Gilead Sciences, Inc., and under National Institutes of Health (NIH) award nos. P50CA244690 (PI: Schnoll) and U48DP006801 (PI: Fayanju) and honoraria for her service on AstraZeneca\u2019s Equity in Action Council. The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The remaining authors have no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}